You
AV

AVROBIO, Inc.

Company · Health · MA
Statements1
Sightings1
Years covered2023 – now
Primary sourceSEC Form 10-K
All statements
2023 – nowCurrentOur purpose is to develop and commercialize HSC gene therapies that free patients from a lifetime of genetic disease.Mission · Product offering · SEC Form 10-K, filed 2023-03-23
Organization
Type
Company
Industry
Health
Location
MA, US
Size
—
Website
—
Status
active
All filings on SEC EDGAR ↗